PRF + PSG for Mandibular Nerve Injury Recovery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if certain treatments can reduce nerve injury after bilateral sagittal split osteotomy (BSSO), a surgery used to correct jaw deformities or sleep apnea. The treatments being tested are platelet-rich fibrin (PRF), which may aid nerve recovery, and proximal segment grooving (PSG), a method that creates space for the nerve. Participants will be assigned to one of four groups: PRF and PSG together, PRF alone, PSG alone, or no treatment, to identify which approach best accelerates nerve recovery. The trial seeks individuals planning to undergo BSSO surgery for jaw issues or obstructive sleep apnea. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance recovery outcomes for future patients.
Do I need to stop my current medications for the trial?
The trial does not specify if you need to stop your current medications, but if you are on treatments like bisphosphonates, blood thinners, corticosteroids, or chemotherapy, you cannot participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
In a previous study, platelet-rich fibrin (PRF) showed promise in aiding nerve healing after surgery. Research indicates that PRF is generally safe and well-tolerated. For example, one study found PRF to be a practical treatment without major safety concerns for patients with other conditions. Another study showed PRF helped with healing and had no severe side effects.
Proximal segment grooving (PSG) is newer and lacks extensive safety data. However, similar surgical techniques have been used safely to aid nerve recovery. This suggests PSG might be safe, but more research is needed to confirm this.
In summary, PRF has a proven safety record, while PSG requires further study to confirm its safety.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for mandibular nerve injury recovery because they offer innovative approaches that differ from standard options like medication, physical therapy, or surgery. Platelet-rich fibrin (PRF) is unique because it uses the patient's own blood components to promote healing and tissue regeneration, potentially speeding up recovery and reducing complications. Proximal segment grooving (PSG) introduces a novel mechanical technique to enhance nerve repair, which could improve outcomes when used alone or in combination with PRF. Together, these treatments might offer a more natural and effective way to restore nerve function compared to traditional methods.
What evidence suggests that this trial's treatments could be effective for mandibular nerve injury recovery?
Research has shown that platelet-rich fibrin (PRF), which participants in this trial may receive, can help repair damaged nerves in the jaw. Studies indicate that PRF significantly reduces pain after surgery, suggesting it aids in healing. Although specific data on proximal segment grooving (PSG) is limited, the concept involves creating space for the nerve to potentially lower the risk of injury. This trial will test PRF alone, PSG alone, and a combination of both treatments to improve nerve recovery after jaw surgery. Early findings suggest both methods could speed up the return of sensation in the chin and lip area.12367
Who Is on the Research Team?
Jesse Han, DDS, MD
Principal Investigator
University of Washington
Are You a Good Fit for This Trial?
This trial is for adults with dentofacial deformities or obstructive sleep apnea who are undergoing a jaw surgery called bilateral sagittal split osteotomy (BSSO). It's not for those who've had previous jaw surgeries, existing nerve issues in the face, trouble understanding the consent process, or conditions that affect healing like being on certain medications.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo bilateral sagittal split osteotomy (BSSO) with randomization into 4 treatment groups: PSG with PRF, PSG alone, PRF alone, or neither PSG nor PRF
Post-operative Monitoring
Objective and subjective post-operative nerve function is measured at fixed intervals
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Platelet-rich fibrin (PRF)
- Proximal segment grooving (PSG)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jesse Han
Lead Sponsor